[
  {
    "ts": "2025-08-04T21:07:00+00:00",
    "headline": "Health Care Roundup: Market Talk",
    "summary": "1449 ET –  Moderna  lowering the upper range of its full-year revenue guidance last week sent its stock falling.  A vaccine for CMV, a virus that causes birth defects, is showing promise, while updates from the company’s oncology development, including in melanoma and bladder and kidney cancers, are expected in the coming years, the analysts say.  The decrease in revenue guidance is likely a result of timing more than fundamentals while the significant cost-cutting initiatives the company recently announced also put it on a path to profitability.",
    "url": "https://www.wsj.com/health/health-care-roundup-market-talk-f82b3388?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "1be85bb1-976f-364a-841b-ae31caada361",
      "content": {
        "id": "1be85bb1-976f-364a-841b-ae31caada361",
        "contentType": "STORY",
        "title": "Health Care Roundup: Market Talk",
        "description": "",
        "summary": "1449 ET –  Moderna  lowering the upper range of its full-year revenue guidance last week sent its stock falling.  A vaccine for CMV, a virus that causes birth defects, is showing promise, while updates from the company’s oncology development, including in melanoma and bladder and kidney cancers, are expected in the coming years, the analysts say.  The decrease in revenue guidance is likely a result of timing more than fundamentals while the significant cost-cutting initiatives the company recently announced also put it on a path to profitability.",
        "pubDate": "2025-08-04T21:07:00Z",
        "displayTime": "2025-08-04T21:07:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/1be85bb1-976f-364a-841b-ae31caada361/health-care-roundup-market.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/925d50bc392450866d0e31a31851fbad",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MazWkMwra25uqkZRdtaNLA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/925d50bc392450866d0e31a31851fbad.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_RYuDsxuMP_RlRIfTmZJBQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/925d50bc392450866d0e31a31851fbad.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/health-care-roundup-market-talk-f82b3388?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-04T15:08:52+00:00",
    "headline": "Moderna Beat COVID Vaccine Revenue Estimates But Still Lowered 2025 Outlook, RBC Says",
    "summary": "Moderna (MRNA) reported Q2 COVID vaccine revenue of $114 million, topping the $89 million analyst es",
    "url": "https://finance.yahoo.com/news/moderna-beat-covid-vaccine-revenue-150852646.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "0bf67c2b-57a7-311c-b267-79ea534d3d90",
      "content": {
        "id": "0bf67c2b-57a7-311c-b267-79ea534d3d90",
        "contentType": "STORY",
        "title": "Moderna Beat COVID Vaccine Revenue Estimates But Still Lowered 2025 Outlook, RBC Says",
        "description": "",
        "summary": "Moderna (MRNA) reported Q2 COVID vaccine revenue of $114 million, topping the $89 million analyst es",
        "pubDate": "2025-08-04T15:08:52Z",
        "displayTime": "2025-08-04T15:08:52Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/moderna-beat-covid-vaccine-revenue-150852646.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/moderna-beat-covid-vaccine-revenue-150852646.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]